No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.
Publication date
2006
Authors
Agudo, A.
Sala, N.
Pera, G.
Capella, G.
Berenguer, A.
Garcia, N.
Palli, D.
Boeing, H.H.
Del Giudice, G.
Saieva, C.
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
Agudo, A, Sala, N, Pera, G, Capella, G, Berenguer, A, Garcia, N, Palli, D, Boeing, H H, Del Giudice, G, Saieva, C, Carneiro, F, Berrino, F, Sacerdote, C, Tumino, R, Panico, S, Berglund, G, Siman, H, Stenling, R, Hallmans, G, Martinez, C, Amiano, P, Barricarte, A, Navarro, C, Quiros, J R, Allen, N, Key, T J, Bingham, S, Khaw, K T, Linseisen, J, Nagel, G, Overvad, K, Tjonneland, A, Olsen, A, Bueno de Mesquita, H B, Boshuizen, H C, Peeters, P H M, Numans, M E, Clavel-Chapelon, F, Boutron-Ruault, M C, Trichopoulou, A, Lund, E, Blaker, H, Jenab, M, Ferrari, P, Norat, T, Riboli, E & Gonzalez, C A 2006, 'No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.', Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 5, pp. 1043-1045.